Literature DB >> 7596378

Immunosuppression for myocarditis.

W J McKenna, M J Davies.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7596378     DOI： 10.1056/NEJM199508033330510

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Acute heart failure.

Authors:  R Delgado; E K Massin; J R Cooper
Journal:  Tex Heart Inst J       Date:  1998

2.  Active versus borderline myocarditis: clinicopathological correlates and prognostic implications.

Authors:  A Angelini; M Crosato; G M Boffa; F Calabrese; V Calzolari; R Chioin; L Daliento; G Thiene
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

Review 3.  [Therapy of dilated cardiomyopathies with and without inflammation].

Authors:  G Hufnagel; S Pankuweit; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 4.  Recognition and optimum management of myocarditis.

Authors:  A L Caforio; W J McKenna
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

5.  111Indium antimyosin antibody imaging of primary myocardial involvement in systemic diseases.

Authors:  L Sarda; P Assayag; E Palazzo; D Vilain; L Guillevin; M Faraggi; O Meyer; D Le Guludec
Journal:  Ann Rheum Dis       Date:  1999-02       Impact factor: 19.103

Review 6.  Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes.

Authors:  Weijian Hang; Chen Chen; John M Seubert; Dao Wen Wang
Journal:  Signal Transduct Target Ther       Date:  2020-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.